Hematology, Transfusion and Cell Therapy (Jan 2023)

Evaluation of RET-He values as an early indicator of iron deficiency anemia in pregnant women

  • Suzane Dal Bó,
  • Ana Luiza Rodrigues Fragoso,
  • Mariela Granero Farias,
  • Dariana Pimentel Gomes Hubner,
  • Simone Martins de Castro

Journal volume & issue
Vol. 45, no. 1
pp. 52 – 57

Abstract

Read online

Introduction: During pregnancy, women are at an increased risk of developing iron-deficiency anemia. Objective: The objective of this study was to assess the diagnostic performance of the reticulocyte hemoglobin equivalent (RET-He) in the early detection of iron-deficiency anemia in a group of pregnant women and to establish a reference range for this parameter in a group of control individuals. Method: A total of 60 patients and 130 control subjects were included in the study. Blood samples collected from the subjects were submitted to a complete blood count and a serum ferritin test and the data were analyzed by comparing the groups and ROC curves. Results: The reference range found for the RET-He was between 29.75pg and 38.24pg, with a median of 35pg. The receiver operating characteristic (ROC) curve analysis for the ferritin parameter showed an area under the curve of 0.732 for the RET-He, 0.586 for hemoglobin, 0.551 for the mean corpuscular hemoglobin concentration and 0.482 for the mean corpuscular volume. Conclusion: Early diagnosis of iron deficiency anemia in pregnancy is essential to prevent damage to both maternal and fetal health. The RET-He presents an excellent potential as an auxiliary tool for the diagnosis of iron deficiency in pregnant women.

Keywords